Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Gill

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium studyG Young, M Manco-Johnson, J C Gill, et al.
The Journal of Pediatrics|August 1, 1985
Inherited absence of OKT4 lymphocyte antigen in a chronically transfused patient with homozygous sickle cell diseaseJ C Gill, J Maples, A Nikaein, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989
Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNAD Ginsburg, B A Konkle, J C Gill, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 7, 2005
B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover studyC M Kessler, J C Gill, G C White, et al.
Journal of Thrombosis and Haemostasis : JTH|August 22, 2009
Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor functionV H Flood, K D Friedman, J C Gill, et al.
Journal of Thrombosis and Haemostasis : JTH|April 18, 2012
Critical von Willebrand factor A1 domain residues influence type VI collagen bindingV H Flood, J C Gill, P A Christopherson, et al.
Journal of Thrombosis and Haemostasis : JTH|April 18, 2012
Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand diseaseV H Flood, J C Gill, P A Christopherson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 5, 2013
Case studies in the management of refractory bleeding in patients with haemophilia A and inhibitorsL A Valentino, G Allen, J C Gill, et al.
The Journal of Pediatrics|April 1, 1986
HTLV-III serology in hemophilia: relationship with immunologic abnormalitiesJ C Gill, J E Menitove, P R Anderson, et al.
Blood|December 1, 1985
Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopeniaM E Eyster, D A Whitehurst, P M Catalano, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium studyG Young, M Manco-Johnson, J C Gill, et al.
The Journal of Pediatrics|August 1, 1985
Inherited absence of OKT4 lymphocyte antigen in a chronically transfused patient with homozygous sickle cell diseaseJ C Gill, J Maples, A Nikaein, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989
Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNAD Ginsburg, B A Konkle, J C Gill, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 7, 2005
B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover studyC M Kessler, J C Gill, G C White, et al.
Journal of Thrombosis and Haemostasis : JTH|August 22, 2009
Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor functionV H Flood, K D Friedman, J C Gill, et al.
Journal of Thrombosis and Haemostasis : JTH|April 18, 2012
Critical von Willebrand factor A1 domain residues influence type VI collagen bindingV H Flood, J C Gill, P A Christopherson, et al.
Journal of Thrombosis and Haemostasis : JTH|April 18, 2012
Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand diseaseV H Flood, J C Gill, P A Christopherson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 5, 2013
Case studies in the management of refractory bleeding in patients with haemophilia A and inhibitorsL A Valentino, G Allen, J C Gill, et al.
The Journal of Pediatrics|April 1, 1986
HTLV-III serology in hemophilia: relationship with immunologic abnormalitiesJ C Gill, J E Menitove, P R Anderson, et al.
Blood|December 1, 1985
Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopeniaM E Eyster, D A Whitehurst, P M Catalano, et al.
Pageof 8